Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All molnupiravir studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchMolnupiravirMolnupiravir (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   All Outcomes    Recent:   

Molnupiravir, a ribonucleoside antiviral prodrug against SARS-CoV-2, alters the voltage-gated sodium current and causes adverse events

Shiau et al., Virology, doi:10.1016/j.virol.2023.109865
Aug 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
In vitro study showing that molnupiravir inhibited sodium channel currents by altering channel gating kinetics, which may explain some of the neurological and gastrointestinal side effects.
Concerns have been raised that the mutagenic mechanism of action may create dangerous variants or cause cancer1-9. Multiple analyses have identified variants potentially created by molnupiravir10-13.
Shiau et al., 7 Aug 2023, peer-reviewed, 7 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperMolnupiravirAll
{ 'indexed': {'date-parts': [[2023, 8, 8]], 'date-time': '2023-08-08T04:25:14Z', 'timestamp': 1691468714904}, 'reference-count': 57, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2023, 8, 1]], 'date-time': '2023-08-01T00:00:00Z', 'timestamp': 1690848000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2023, 8, 1]], 'date-time': '2023-08-01T00:00:00Z', 'timestamp': 1690848000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-017'}, { 'start': { 'date-parts': [[2023, 8, 1]], 'date-time': '2023-08-01T00:00:00Z', 'timestamp': 1690848000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-037'}, { 'start': { 'date-parts': [[2023, 8, 1]], 'date-time': '2023-08-01T00:00:00Z', 'timestamp': 1690848000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-012'}, { 'start': { 'date-parts': [[2023, 8, 1]], 'date-time': '2023-08-01T00:00:00Z', 'timestamp': 1690848000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-029'}, { 'start': { 'date-parts': [[2023, 8, 1]], 'date-time': '2023-08-01T00:00:00Z', 'timestamp': 1690848000000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-004'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.com.au', 'clinicalkey.es', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2023, 8]]}, 'DOI': '10.1016/j.virol.2023.109865', 'type': 'journal-article', 'created': {'date-parts': [[2023, 8, 8]], 'date-time': '2023-08-08T00:36:35Z', 'timestamp': 1691454995000}, 'page': '109865', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Molnupiravir, a ribonucleoside antiviral prodrug against SARS-CoV-2, alters the voltage-gated ' 'sodium current and causes adverse events', 'prefix': '10.1016', 'author': [ {'given': 'Ai-Li', 'family': 'Shiau', 'sequence': 'first', 'affiliation': []}, {'given': 'Kuan-Hsien', 'family': 'Lee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hsin-Yen', 'family': 'Cho', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tzu-Hsien', 'family': 'Chuang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Meng-Cheng', 'family': 'Yu', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7821-9406', 'authenticated-orcid': False, 'given': 'Chao-Liang', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sheng-Nan', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': '17', 'key': '10.1016/j.virol.2023.109865_bib1', 'doi-asserted-by': 'crossref', 'first-page': '4602', 'DOI': '10.1523/JNEUROSCI.5204-05.2006', 'article-title': 'Interaction of Kv3 potassium channels and resurgent sodium current ' 'influences the rate of spontaneous firing of Purkinje neurons', 'volume': '26', 'author': 'Akemann', 'year': '2006', 'journal-title': 'J. Neurosci.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib2', 'doi-asserted-by': 'crossref', 'first-page': '5', 'DOI': '10.1177/1756283X11415892', 'article-title': 'Targeting ion channels for the treatment of gastrointestinal motility ' 'disorders', 'volume': '5', 'author': 'Beyder', 'year': '2012', 'journal-title': 'Therap Adv Gastroenterol'}, { 'issue': '7', 'key': '10.1016/j.virol.2023.109865_bib3', 'doi-asserted-by': 'crossref', 'first-page': '1659', 'DOI': '10.1053/j.gastro.2014.02.054', 'article-title': 'Loss-of-function of the voltage-gated sodium channel NaV1.5 ' '(channelopathies) in patients with irritable bowel syndrome', 'volume': '146', 'author': 'Beyder', 'year': '2014', 'journal-title': 'Gastroenterology'}, { 'key': '10.1016/j.virol.2023.109865_bib4', 'doi-asserted-by': 'crossref', 'first-page': '133', 'DOI': '10.1146/annurev-pharmtox-010818-021757', 'article-title': 'Structure and pharmacology of voltage-gated sodium and calcium channels', 'volume': '60', 'author': 'Catterall', 'year': '2020', 'journal-title': 'Annu. Rev. Pharmacol. Toxicol.'}, { 'key': '10.1016/j.virol.2023.109865_bib5', 'doi-asserted-by': 'crossref', 'first-page': '1091', 'DOI': '10.3389/fphar.2020.01091', 'article-title': 'Evidence for the effectiveness of remdesivir (GS-5734), a ' 'nucleoside-analog anti-viral drug in the inhibition of Ik(M) or Ik(DR) ' 'and in the stimulation of IMEP', 'volume': '11', 'author': 'Chang', 'year': '2020', 'journal-title': 'Front. Pharmacol.'}, { 'issue': '5', 'key': '10.1016/j.virol.2023.109865_bib6', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/biomedicines9050549', 'article-title': 'Characterization of direct perturbations on voltage-gated sodium ' 'current by esaxerenone, a nonsteroidal mineralocorticoid receptor ' 'blocker', 'volume': '9', 'author': 'Chang', 'year': '2021', 'journal-title': 'Biomedicines'}, { 'issue': '3', 'key': '10.1016/j.virol.2023.109865_bib7', 'doi-asserted-by': 'crossref', 'first-page': '295', 'DOI': '10.1254/jphs.09018FP', 'article-title': 'Effects of ranolazine, a novel anti-anginal drug, on ion currents and ' 'membrane potential in pituitary tumor GH(3) cells and NG108-15 neuronal ' 'cells', 'volume': '110', 'author': 'Chen', 'year': '2009', 'journal-title': 'J. Pharmacol. Sci.'}, { 'issue': '2', 'key': '10.1016/j.virol.2023.109865_bib8', 'doi-asserted-by': 'crossref', 'first-page': '244', 'DOI': '10.1093/bja/aep107', 'article-title': 'Dexmedetomidine, an alpha2-adrenergic agonist, inhibits neuronal ' 'delayed-rectifier potassium current and sodium current', 'volume': '103', 'author': 'Chen', 'year': '2009', 'journal-title': 'Br. J. Anaesth.'}, { 'issue': '3', 'key': '10.1016/j.virol.2023.109865_bib9', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/biomedicines10030721', 'article-title': 'Activation of voltage-gated Na(+) current by GV-58, a known activator ' 'of Ca(V) channels', 'volume': '10', 'author': 'Cho', 'year': '2022', 'journal-title': 'Biomedicines'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib10', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/biomedicines10010086', 'article-title': 'The evidence for sparsentan-mediated inhibition of I(Na) and I(K(erg)): ' 'possibly unlinked to its antagonism of angiotensin II or endothelin ' 'type a receptor', 'volume': '10', 'author': 'Chuang', 'year': '2021', 'journal-title': 'Biomedicines'}, { 'issue': '10', 'key': '10.1016/j.virol.2023.109865_bib11', 'article-title': 'Ionic mechanisms maintaining action potential conduction velocity at ' 'high firing frequencies in an unmyelinated axon', 'volume': '4', 'author': 'Cross', 'year': '2016', 'journal-title': 'Phys. Rep.'}, { 'issue': '15–16', 'key': '10.1016/j.virol.2023.109865_bib12', 'doi-asserted-by': 'crossref', 'first-page': '564', 'DOI': '10.1016/j.lfs.2011.05.016', 'article-title': 'Resurgent Na+ current: a new avenue to neuronal excitability control', 'volume': '89', 'author': 'Cruz', 'year': '2011', 'journal-title': 'Life Sci.'}, { 'issue': '18', 'key': '10.1016/j.virol.2023.109865_bib13', 'doi-asserted-by': 'crossref', 'first-page': '7093', 'DOI': '10.1021/jm501981g', 'article-title': 'Voltage-gated sodium channels: structure, function, pharmacology, and ' 'clinical indications', 'volume': '58', 'author': 'de Lera Ruiz', 'year': '2015', 'journal-title': 'J. Med. Chem.'}, { 'issue': '2', 'key': '10.1016/j.virol.2023.109865_bib14', 'doi-asserted-by': 'crossref', 'first-page': '305', 'DOI': '10.1002/jnr.24134', 'article-title': 'Development of resurgent and persistent sodium currents in ' 'mesencephalic trigeminal neurons', 'volume': '96', 'author': 'Enomoto', 'year': '2018', 'journal-title': 'J. Neurosci. Res.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib15', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.celrep.2021.108940', 'article-title': 'Anti-viral drug screen identifies DNA-damage response inhibitor as ' 'potent blocker of SARS-CoV-2 replication', 'volume': '35', 'author': 'Garcia', 'year': '2021', 'journal-title': 'Cell Rep.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib16', 'doi-asserted-by': 'crossref', 'first-page': '62', 'DOI': '10.1016/j.neulet.2009.01.066', 'article-title': 'mu-Opioid receptor-independent fashion of the suppression of sodium ' 'currents by mu-opioid analgesics in thalamic neurons', 'volume': '453', 'author': 'Hashimoto', 'year': '2009', 'journal-title': 'Neurosci. Lett.'}, { 'issue': '3', 'key': '10.1016/j.virol.2023.109865_bib17', 'doi-asserted-by': 'crossref', 'first-page': '423', 'DOI': '10.1113/JP275083', 'article-title': 'Resurgent sodium current promotes action potential firing in the avian ' 'auditory brainstem', 'volume': '596', 'author': 'Hong', 'year': '2018', 'journal-title': 'J. Physiol.'}, { 'issue': '6', 'key': '10.1016/j.virol.2023.109865_bib18', 'doi-asserted-by': 'crossref', 'first-page': '1318', 'DOI': '10.3390/biomedicines10061318', 'article-title': 'Inhibitory effectiveness in delayed-rectifier potassium current caused ' 'by vortioxetine, known to Be a novel antidepressant', 'volume': '10', 'author': 'Hsiao', 'year': '2022', 'journal-title': 'Biomedicines'}, { 'key': '10.1016/j.virol.2023.109865_bib19', 'doi-asserted-by': 'crossref', 'first-page': '125', 'DOI': '10.1016/j.neuroscience.2014.12.026', 'article-title': 'The inhibitory actions by lacosamide, a functionalized amino acid, on ' 'voltage-gated Na+ currents', 'volume': '287', 'author': 'Huang', 'year': '2015', 'journal-title': 'Neuroscience'}, { 'issue': '19', 'key': '10.1016/j.virol.2023.109865_bib20', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/molecules26195795', 'article-title': 'Discovery, development, and patent trends on molnupiravir: a ' 'prospective oral treatment for COVID-19', 'volume': '26', 'author': 'Imran', 'year': '2021', 'journal-title': 'Molecules'}, { 'issue': '6', 'key': '10.1016/j.virol.2023.109865_bib21', 'doi-asserted-by': 'crossref', 'first-page': '509', 'DOI': '10.1056/NEJMoa2116044', 'article-title': 'Molnupiravir for oral treatment of covid-19 in nonhospitalized patients', 'volume': '386', 'author': 'Jayk Bernal', 'year': '2022', 'journal-title': 'N. Engl. J. Med.'}, { 'issue': '2', 'key': '10.1016/j.virol.2023.109865_bib22', 'doi-asserted-by': 'crossref', 'first-page': '164', 'DOI': '10.2174/09298673113206660257', 'article-title': 'Isoform selective voltage-gated sodium channel modulators and the ' 'therapy of pain', 'volume': '21', 'author': 'Jukič', 'year': '2014', 'journal-title': 'Curr. Med. Chem.'}, { 'issue': '17', 'key': '10.1016/j.virol.2023.109865_bib23', 'doi-asserted-by': 'crossref', 'first-page': '6639', 'DOI': '10.1523/JNEUROSCI.17-17-06639.1997', 'article-title': 'Prolonged sodium channel inactivation contributes to dendritic action ' 'potential attenuation in hippocampal pyramidal neurons', 'volume': '17', 'author': 'Jung', 'year': '1997', 'journal-title': 'J. Neurosci.'}, { 'issue': '9', 'key': '10.1016/j.virol.2023.109865_bib24', 'doi-asserted-by': 'crossref', 'first-page': '740', 'DOI': '10.1038/s41594-021-00651-0', 'article-title': 'Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis', 'volume': '28', 'author': 'Kabinger', 'year': '2021', 'journal-title': 'Nat. Struct. Mol. Biol.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib25', 'doi-asserted-by': 'crossref', 'first-page': '162', 'DOI': '10.1124/mol.113.088492', 'article-title': 'Ranolazine reduces neuronal excitability by interacting with ' 'inactivated states of brain sodium channels', 'volume': '85', 'author': 'Kahlig', 'year': '2014', 'journal-title': 'Mol. Pharmacol.'}, { 'issue': '12', 'key': '10.1016/j.virol.2023.109865_bib26', 'doi-asserted-by': 'crossref', 'first-page': '4899', 'DOI': '10.1523/JNEUROSCI.23-12-04899.2003', 'article-title': 'The contribution of resurgent sodium current to high-frequency firing ' 'in Purkinje neurons: an experimental and modeling study', 'volume': '23', 'author': 'Khaliq', 'year': '2003', 'journal-title': 'J. Neurosci.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib27', 'doi-asserted-by': 'crossref', 'first-page': '2342', 'DOI': '10.1038/s41467-019-10280-3', 'article-title': 'Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 ' 'co-factors', 'volume': '10', 'author': 'Kirchdoerfer', 'year': '2019', 'journal-title': 'Nat. Commun.'}, { 'issue': '22', 'key': '10.1016/j.virol.2023.109865_bib28', 'doi-asserted-by': 'crossref', 'first-page': '4825', 'DOI': '10.1113/jphysiol.2014.277582', 'article-title': 'Resurgent current of voltage-gated Na(+) channels', 'volume': '592', 'author': 'Lewis', 'year': '2014', 'journal-title': 'J. Physiol.'}, { 'issue': 'Pt 1', 'key': '10.1016/j.virol.2023.109865_bib29', 'doi-asserted-by': 'crossref', 'first-page': '83', 'DOI': '10.1113/jphysiol.2006.106682', 'article-title': 'Kinetic and functional analysis of transient, persistent and resurgent ' 'sodium currents in rat cerebellar granule cells in situ: an ' 'electrophysiological and modelling study', 'volume': '573', 'author': 'Magistretti', 'year': '2006', 'journal-title': 'J. Physiol.'}, { 'key': '10.1016/j.virol.2023.109865_bib30', 'first-page': '1', 'article-title': 'Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic ' 'review', 'author': 'Mali', 'year': '2022', 'journal-title': 'Ir. J. Med. Sci.'}, { 'issue': '6', 'key': '10.1016/j.virol.2023.109865_bib31', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/antiox10060979', 'article-title': 'Electron donor-acceptor capacity of selected pharmaceuticals against ' 'COVID-19', 'volume': '10', 'author': 'Martínez', 'year': '2021', 'journal-title': 'Antioxidants'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib32', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.jbc.2021.100867', 'article-title': 'Decoding molnupiravir-induced mutagenesis in SARS-CoV-2', 'volume': '297', 'author': 'Menéndez-Arias', 'year': '2021', 'journal-title': 'J. Biol. Chem.'}, { 'key': '10.1016/j.virol.2023.109865_bib33', 'doi-asserted-by': 'crossref', 'DOI': '10.7554/eLife.54940', 'article-title': 'Sodium channels implement a molecular leaky integrator that detects ' 'action potentials and regulates neuronal firing', 'volume': '9', 'author': 'Navarro', 'year': '2020', 'journal-title': 'Elife'}, { 'issue': '2', 'key': '10.1016/j.virol.2023.109865_bib34', 'first-page': '167', 'article-title': 'Aconitine-induced modification of single sodium channels in ' 'neuroblastoma cell membrane', 'volume': '9', 'author': 'Negulyaev Yu', 'year': '1990', 'journal-title': 'Gen. Physiol. Biophys.'}, { 'key': '10.1016/j.virol.2023.109865_bib35', 'doi-asserted-by': 'crossref', 'first-page': '17', 'DOI': '10.1016/j.coviro.2021.06.003', 'article-title': 'Developing a direct acting, orally available anti-viral agent in a ' 'pandemic: the evolution of molnupiravir as a potential treatment for ' 'COVID-19', 'volume': '50', 'author': 'Painter', 'year': '2021', 'journal-title': 'Curr Opin Virol'}, { 'issue': '5', 'key': '10.1016/j.virol.2023.109865_bib36', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/AAC.02428-20', 'article-title': 'Human safety, tolerability, and pharmacokinetics of molnupiravir, a ' 'novel broad-spectrum oral anti-viral agent with activity against ' 'SARS-CoV-2', 'volume': '65', 'author': 'Painter', 'year': '2021', 'journal-title': 'Antimicrob. Agents Chemother.'}, { 'key': '10.1016/j.virol.2023.109865_bib37', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fncel.2021.760610', 'article-title': 'Resurgent sodium current in neurons of the cerebral cortex', 'volume': '15', 'author': 'Quattrocolo', 'year': '2021', 'journal-title': 'Front. Cell. Neurosci.'}, { 'issue': '7', 'key': '10.1016/j.virol.2023.109865_bib38', 'doi-asserted-by': 'crossref', 'first-page': '553', 'DOI': '10.1038/nrn1430', 'article-title': 'The neurobiology of antiepileptic drugs', 'volume': '5', 'author': 'Rogawski', 'year': '2004', 'journal-title': 'Nat. Rev. Neurosci.'}, { 'issue': '6', 'key': '10.1016/j.virol.2023.109865_bib39', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.dsx.2021.102329', 'article-title': 'Molnupiravir in COVID-19: a systematic review of literature', 'volume': '15', 'author': 'Singh', 'year': '2021', 'journal-title': 'Diabetes Metabol. Syndr.'}, { 'key': '10.1016/j.virol.2023.109865_bib40', 'doi-asserted-by': 'crossref', 'first-page': '104', 'DOI': '10.1016/j.toxlet.2018.01.002', 'article-title': 'Differential regulation of tefluthrin and telmisartan on the gating ' 'charges of INa activation and inactivation as well as on resurgent and ' 'persistent INa in a pituitary cell line (GH3)', 'volume': '285', 'author': 'So', 'year': '2018', 'journal-title': 'Toxicol. Lett.'}, { 'issue': '5', 'key': '10.1016/j.virol.2023.109865_bib41', 'doi-asserted-by': 'crossref', 'first-page': '2053', 'DOI': '10.1159/000475436', 'article-title': 'Synergistic inhibition of delayed rectifier K+ and voltage-gated Na+ ' 'currents by artemisinin in pituitary tumor (GH3) cells', 'volume': '41', 'author': 'So', 'year': '2017', 'journal-title': 'Cell. Physiol. Biochem.'}, { 'key': '10.1016/j.virol.2023.109865_bib42', 'doi-asserted-by': 'crossref', 'first-page': '845', 'DOI': '10.1210/er.2010-0005', 'article-title': 'Ion channels and signaling in the pituitary gland', 'volume': '31', 'author': 'Stojilkov', 'year': '2010', 'journal-title': 'Endocr. Rev.'}, { 'issue': '6', 'key': '10.1016/j.virol.2023.109865_bib43', 'doi-asserted-by': 'crossref', 'first-page': '1160', 'DOI': '10.1016/j.molcel.2020.12.048', 'article-title': 'A tamoxifen receptor within a voltage-gated sodium channel', 'volume': '81', 'author': 'Sula', 'year': '2021', 'journal-title': 'Mol. Cell'}, { 'key': '10.1016/j.virol.2023.109865_bib44', 'doi-asserted-by': 'crossref', 'first-page': '338', 'DOI': '10.2119/molmed.2016.00131', 'article-title': 'A gain-of-function mutation in Nav1.6 in a case of trigeminal neuralgia', 'volume': '22', 'author': 'Tanaka', 'year': '2016', 'journal-title': 'Mol. Med.'}, { 'issue': '3', 'key': '10.1016/j.virol.2023.109865_bib45', 'doi-asserted-by': 'crossref', 'first-page': '275', 'DOI': '10.3748/wjg.v28.i3.275', 'article-title': 'Endothelial cells and blood vessels are major targets for ' 'COVID-19-induced tissue injury and spreading to various organs', 'volume': '28', 'author': 'Tarnawski', 'year': '2022', 'journal-title': 'World J. Gastroenterol.'}, { 'key': '10.1016/j.virol.2023.109865_bib46', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fimmu.2022.855496', 'article-title': 'Molnupiravir and its anti-viral activity against COVID-19', 'volume': '13', 'author': 'Tian', 'year': '2022', 'journal-title': 'Front. Immunol.'}, { 'key': '10.1016/j.virol.2023.109865_bib47', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2022.105252', 'article-title': 'Remdesivir, Molnupiravir and Nirmatrelvir remain active against ' 'SARS-CoV-2 Omicron and other variants of concern', 'volume': '198', 'author': 'Vangeel', 'year': '2022', 'journal-title': 'Antivir. Res.'}, { 'issue': '6', 'key': '10.1016/j.virol.2023.109865_bib48', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pcbi.1007154', 'article-title': 'Resurgent Na+ current offers noise modulation in bursting neurons', 'volume': '15', 'author': 'Venugopal', 'year': '2019', 'journal-title': 'PLoS Comput. Biol.'}, { 'issue': '7', 'key': '10.1016/j.virol.2023.109865_bib49', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/ijms23073845', 'article-title': 'The evidence for effective inhibition of I(Na) produced by mirogabalin ' '((1R,5S,6S)-6-(aminomethyl)-3-ethyl-bicyclo [3.2.0] hept-3-ene-6-acetic ' 'acid), a known blocker of Ca(V) channels', 'volume': '23', 'author': 'Wu', 'year': '2022', 'journal-title': 'Int. J. Mol. Sci.'}, { 'issue': '12', 'key': '10.1016/j.virol.2023.109865_bib50', 'doi-asserted-by': 'crossref', 'first-page': '3409', 'DOI': '10.1002/jcp.25788', 'article-title': 'Stimulatory actions of a novel thiourea derivative on ' 'large-conductance, calcium-activated potassium channels', 'volume': '232', 'author': 'Wu', 'year': '2017', 'journal-title': 'J. Cell. Physiol.'}, { 'issue': '6', 'key': '10.1016/j.virol.2023.109865_bib51', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/ijms22062956', 'article-title': 'Editorial to the special issue "electrophysiology', 'volume': '22', 'author': 'Wu', 'year': '2021', 'journal-title': 'Int. J. Mol. Sci.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib52', 'doi-asserted-by': 'crossref', 'first-page': '70', 'DOI': '10.1016/j.tox.2009.01.009', 'article-title': 'Underlying mechanism of actions of tefluthrin, a pyrethroid ' 'insecticide, on voltage-gated ion currents and on action currents in ' 'pituitary tumor (GH3) cells and GnRH-secreting (GT1-7) neurons', 'volume': '258', 'author': 'Wu', 'year': '2009', 'journal-title': 'Toxicology'}, { 'issue': '2', 'key': '10.1016/j.virol.2023.109865_bib53', 'doi-asserted-by': 'crossref', 'first-page': '120', 'DOI': '10.1111/j.1748-1716.2012.02438.x', 'article-title': 'Electrophysiological characterization of sodium-activated potassium ' 'channels in NG108-15 and NSC-34 motor neuron-like cells', 'volume': '206', 'author': 'Wu', 'year': '2012', 'journal-title': 'Acta Physiol.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib54', 'first-page': '1', 'article-title': 'Molnupiravir, favipiravir and other anti-viral drugs with proposed ' 'potentials for management of COVID-19: a concern on antioxidant aspect', 'volume': '13', 'author': 'Yasri', 'year': '2022', 'journal-title': 'Int J Biochem Mol Biol'}, { 'key': '10.1016/j.virol.2023.109865_bib55', 'first-page': '1', 'article-title': 'Review on molnupiravir as a promising oral drug for the treatment of ' 'COVID-19', 'author': 'Zarenezhad', 'year': '2022', 'journal-title': 'Med. Chem. Res.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib56', 'doi-asserted-by': 'crossref', 'first-page': '6762', 'DOI': '10.1038/s41467-021-26521-3', 'article-title': 'Resurgent Na(+) currents promote ultrafast spiking in projection ' 'neurons that drive fine motor control', 'volume': '12', 'author': 'Zemel', 'year': '2021', 'journal-title': 'Nat. Commun.'}, { 'issue': '1', 'key': '10.1016/j.virol.2023.109865_bib57', 'doi-asserted-by': 'crossref', 'first-page': '410', 'DOI': '10.1038/s41392-021-00837-4', 'article-title': 'A novel model of molnupiravir against SARS-CoV-2 replication: ' 'accumulated RNA mutations to induce error catastrophe', 'volume': '6', 'author': 'Zhao', 'year': '2021', 'journal-title': 'Signal Transduct. Targeted Ther.'}], 'container-title': 'Virology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0042682223001782?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0042682223001782?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 8, 8]], 'date-time': '2023-08-08T00:36:59Z', 'timestamp': 1691455019000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0042682223001782'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 8]]}, 'references-count': 57, 'alternative-id': ['S0042682223001782'], 'URL': 'http://dx.doi.org/10.1016/j.virol.2023.109865', 'relation': {}, 'ISSN': ['0042-6822'], 'subject': ['Virology'], 'container-title-short': 'Virology', 'published': {'date-parts': [[2023, 8]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Molnupiravir, a ribonucleoside antiviral prodrug against SARS-CoV-2, alters the ' 'voltage-gated sodium current and causes adverse events', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Virology', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.virol.2023.109865', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2023 Elsevier Inc. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '109865'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit